Prospective collection of data and biomaterial of COVID-19 at the location Würzburg

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00022402
• Lead Sponsor: niversitätsklinikum Würzburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-09
• Study Completion: 2022-12-20
• Results First Posted: 2023-04-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 94

Inclusion Criteria

Symptomatic COVID-19 infection,
Hospital admission

Exclusion Criteria

None

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality: Registration via clinical information system or (when consent has been given) by information of relatives or family doctor. Data is collected at baseline (during hospital stay), 3, 12 and 24 months after admission.<br><br>Non-fatal complication: pulmonary co-infection, bloodstream infection, thromboembolic event. Data is collected at baseline (during hospital stay) via clinical information system.<br><br>Quality of life: Registration via structured interview and standardized questionnaire (EQ-5D). Data is collected at 3, 12 and 24 months after admission.<br>

Secondary Outcome Measures

Name	Time	Method
identification of immune response or comorbidities due to COVID-19 infection